Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Lymphatic Diseases
>>
Novartis
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
Tasigna
(nilotinib) / Novartis, Inhibikase
Jakafi
(ruxolitinib) / Incyte
Promacta
(eltrombopag) / Novartis
buparlisib
(AN2025) / Novartis, Adlai Nortye, Nippon Kayaku
patupilone
(EPO 906) / Novartis
Simulect
(basiliximab) / Novartis
Mekinist
(trametinib) / Novartis, BeiGene
Rydapt
(midostaurin) / Novartis
Tafinlar
(dabrafenib) / Novartis, BeiGene
Votrient
(pazopanib) / Novartis, BeiGene
lucatumumab
(CHIR 12.12) / Novartis, Xoma
octreotide acetate
/ Generic mfg.
vatalanib
(PTK787) / Novartis, Bayer
